abiraterone has been researched along with bromochloroacetic acid in 2 studies
Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (bromochloroacetic acid) | Trials (bromochloroacetic acid) | Recent Studies (post-2010) (bromochloroacetic acid) |
---|---|---|---|---|---|
942 | 97 | 854 | 22,219 | 258 | 3,378 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
A'Hern, R; Attard, G; Carden, CP; Cooper, CS; Coumans, F; Cox, ME; de Bono, JS; Dearnaley, D; Hawche, G; Jameson, C; Kaye, SB; Levink, R; Molina, A; Moreira, J; Olmos, D; Oommen, NB; Parker, C; Reid, AH; Riisnaes, R; Sipkema, R; Swennenhuis, JF; Terstappen, LW; Thompson, E; Vickers, E | 1 |
Antonarakis, ES; Armstrong, AJ; Barnett, E; Carbone, E; Danila, DC; Dos Anjos, CH; George, D; Gill, A; Gonen, M; Halabi, S; Lu, J; Luo, J; Scher, HI; Schonhoft, JD; Szmulewitz, R; Tagawa, S; Wenstrup, R; Yang, Q; Zhao, JL | 1 |
2 other study(ies) available for abiraterone and bromochloroacetic acid
Article | Year |
---|---|
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.
Topics: Androstenes; Androstenols; Antigens, Neoplasm; Cell Adhesion Molecules; Epithelial Cell Adhesion Molecule; Gene Order; Humans; Immunomagnetic Separation; In Situ Hybridization, Fluorescence; Keratins; Male; Neoplasms, Hormone-Dependent; Neoplastic Cells, Circulating; Oncogene Proteins, Fusion; Prostatic Neoplasms; PTEN Phosphohydrolase; Receptors, Androgen; Trans-Activators; Transcriptional Regulator ERG | 2009 |
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Benzamides; Biomarkers, Tumor; Cell Count; Clinical Decision-Making; Humans; Keratins; Leukocyte Common Antigens; Male; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Nitriles; Phenylthiohydantoin; Predictive Value of Tests; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Reproducibility of Results | 2021 |